GSK releases positive data on long-acting HIV treatment
GSK announces that its injectable HIV treatment was able to suppress the virus when administered every two months.
Top Headlines
Global Industry News
-
Pfizer puts $500m into gene therapy, expands manufacturing facility
from BioPharma-Reporter.com
-
Researchers create miniature livers to support NASH R&D
from Outsourcing-Pharma.com
-
Machine learning model forecasts Alzheimer’s-driven cognitive decline
from Outsourcing-Pharma.com
-
US funds additional year of Ebola vaccine manufacture
from BioPharma-Reporter.com
Hot Topics
-
FDA makes example out of Chinese OTC manufacturer
Globalisation
-
Roche’s tumour-agnostic drug approved by FDA, priced under competitor drug
Bioavailability Challenge
-
Will pharma M&A keep up the pace in second half of 2019?
Mergers and Acquisitions
-
AI platform identifies anti-cancer uses in non-cancer generics
Bioavailability Challenge
